Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- NJIT Researcher Fortifies Virtual Reality Tech for Cancer Patient Emergencies.
- Join Us Today for Rutgers Health Policy and Advocacy Corps
- Rutgers-Newark Launches Institute on Improving Communities Through AI and Interdisciplinary Data Work.
- New Jersey Voters Say Finding Quality, Affordable Child Care Is Difficult and a Major Barrier for Working Parents.
Categories
- Community (2,385)
- Covid (993)
- CTO Events (6)
- News (3,023)
- Pilots (21)